Furthermore, treatment with all three doses resulted in comparable immuno-pharmacodynamic effects in the tumor, as evidenced by flow cytometric analysis of human CD4+ and CD8+ T cell infiltration (Figure 5C). The gene discussed is CD4; the disease is neoplasm.